| Date | Time | Source | Headline | Symbol | Company |
| 03/07/2011 | 2:58PM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist & Deregister Contingent Value Rights for APP Pharmaceuti... | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/23/2011 | 6:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/23/2011 | 6:04AM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/23/2011 | 1:01AM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 01/26/2011 | 8:00AM | Business Wire | APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 11/30/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Announces Approval and Launch of Topotecan for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 11/05/2010 | 3:39PM | Business Wire | APP Pharmaceuticals to Launch Drug Hotline | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 11/02/2010 | 6:04AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 11/01/2010 | 8:16PM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 10/29/2010 | 6:53PM | Business Wire | APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 08/02/2010 | 7:15PM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 08/02/2010 | 5:16PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 07/27/2010 | 1:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 07/06/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/29/2010 | 2:44PM | Edgar (US Regulatory) | Annual Report of Employee Stock Plans (11-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/29/2010 | 1:01AM | Business Wire | APP Pharmaceuticals to Market Anastrozole Tablets in the U.S. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/22/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/21/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/11/2010 | 1:01AM | Business Wire | APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 06/08/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 05/10/2010 | 6:07AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 05/04/2010 | 6:04AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 05/03/2010 | 6:41PM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 04/01/2010 | 11:39AM | Business Wire | Fresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventis | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 03/31/2010 | 5:27PM | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 03/25/2010 | 9:15AM | GlobeNewswire Inc. | Emerging Stock Report Initiates Independent Research Coverage on Fresenius Kabi Pharmaceuticals Holding, Inc. | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 03/23/2010 | 1:01AM | Business Wire | APP Pharmaceuticals Receives Approval for Indomethacin for Injection | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/25/2010 | 3:43PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/24/2010 | 6:03AM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |
| 02/23/2010 | 8:08PM | Business Wire | Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-K | NASDAQ:APCVZ | Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) |